{"title":"Procept BioRobotics vs Zimmer Biomet: Medical & surgical compared","url":"https://www.frontiertechintelligence.com/compare/procept-biorobotics-vs-zimmer-biomet","comparison":"Zimmer Biomet ranks 60 on the Robotics 100 with a score of 81; Procept BioRobotics ranks 88 with 78. Zimmer Biomet is ahead on firepower. Level on deployment, production, commercials, progress, technology, positioning and leverage. Procept BioRobotics is based in San Jose, United States, Zimmer Biomet in Warsaw, United States. Procept BioRobotics: Established. Zimmer Biomet: Public. Procept BioRobotics is named in 9 signals and Zimmer Biomet in 11.","companies":[{"name":"Procept BioRobotics","url":"https://www.frontiertechintelligence.com/companies/procept-biorobotics","city":"San Jose","country":"United States","stage":"Established","founded":null,"last_round":null,"positioning":"Procept BioRobotics is a US surgical-robotics maker whose Aquablation system runs about 12,200 US procedures a quarter, with FY26 guidance of $390-410M (+27-33%). It gained FDA clearance for its second-generation FirstAssist AI in Q1-26, an EAU guideline recommending Aquablation over TURP, and its first UK Hydros units at ASPs above $400k. It is not yet profitable (Q1-26 net loss widened to $31.6M), with adjusted-EBITDA breakeven targeted for Q4-26.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":88,"score":78,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":8,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Procept BioRobotics develops and sells robotic surgical systems for urologic procedures, including the AquaBeam Robotic System for waterjet ablation in benign prostatic hyperplasia treatment.","segment":"Medical & surgical","layer":"Systems"},"signals_total":9,"facts_total":2},{"name":"Zimmer Biomet","url":"https://www.frontiertechintelligence.com/companies/zimmer-biomet","city":"Warsaw","country":"United States","stage":"Public","founded":null,"last_round":null,"positioning":"Zimmer Biomet is a US orthopedics company (NYSE:ZBH) whose ROSA robotic platform serves knee, hip, and shoulder procedures, now adding the Monogram semi-autonomous TKA system (FDA 510(k) in March 2025, an early-2027 launch) with a fully autonomous version in clinical study since July 2025. It completed the Monogram Technologies acquisition in October 2025. ROSA-specific revenue is not broken out of the group.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":60,"score":81,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Zimmer Biomet develops and sells ROSA robotic surgical systems for orthopedic procedures, including robotic assistance and navigation for knee, hip, and brain surgery.","segment":"Medical & surgical","layer":"Systems"},"signals_total":11,"facts_total":4}],"note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}